galactocerebroside

Galactocerebroside, also known as galactosylceramide, is a neutral glycosphingolipid composed of a ceramide backbone linked to a single galactose residue. It is a major lipid constituent of myelin in the central nervous system and is also found in the membranes of oligodendrocytes and, to a lesser extent, Schwann cells in the peripheral nervous system.

Biochemically, galactocerebroside is synthesized in the Golgi apparatus by the enzyme UDP-galactose:ceramide galactosyltransferase, which transfers galactose from UDP-galactose to ceramide. In myelin, it contributes to membrane structure and stability. Galactocerebroside can be further modified to form sulfatides (galactosylsulfatide) through the action of a sulfotransferase.

Degradation of galactocerebroside occurs in lysosomes via the enzyme galactocerebrosidase (GALC). Deficiency of GALC leads to Krabbe disease (globoid cell leukodystrophy), a severe neurodegenerative lysosomal storage disorder characterized by demyelination and progressive neurologic decline. Pathology involves accumulation of galactocerebroside and the toxic lipid psychosine in glial cells, contributing to myelin loss.

Clinical relevance of galactocerebroside centers on its role as a characteristic myelin lipid; it serves as a biochemical and histological marker of myelin-rich tissues. Abnormalities in its metabolism are linked to demyelinating conditions, and the lipid is a focus of study in research on myelin biology and nervous system diseases. Variants of the galactosylceramide molecule reflect the heterogeneity of the ceramide moiety within myelin.